Bernstein has lowered its price target on UnitedHealth Group to $337 from $377 while keeping an ‘Outperform’ rating on the ...

Discover why this undervalued company, potentially 135% below true value, might present growth opportunities despite missing ...

UNH's oversold status has been overly done, as the market digests the market-wide headwinds arising from regulatory changes ...